Ventyx Biosciences, Inc. (VTYX): Price and Financial Metrics

Ventyx Biosciences, Inc. (VTYX): $2.15

0.01 (-0.46%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add VTYX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#207 of 328

in industry

VTYX Price/Volume Stats

Current price $2.15 52-week high $15.81
Prev. close $2.16 52-week low $1.79
Day low $2.14 Volume 607,500
Day high $2.24 Avg. volume 2,083,894
50-day MA $2.25 Dividend yield N/A
200-day MA $3.57 Market Cap 151.94M

VTYX Stock Price Chart Interactive Chart >


Ventyx Biosciences, Inc. (VTYX) Company Bio


Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that has completed phase I clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases. In addition, the company develops CNS-penetrant NLRP3 inhibitors. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.


VTYX Latest News Stream


Event/Time News Detail
Loading, please wait...

VTYX Latest Social Stream


Loading social stream, please wait...

View Full VTYX Social Stream

VTYX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!